Urologic OncologyUnited States
University of Texas MD Anderson Cancer Center
Houston, TX
Two-year SUO-accredited program in complex robotic, laparoscopic and open urologic cancer surgery, including many salvage open operations, with basic and translational research under a dedicated scientist mentor.
Length2 years (additional research years optional)
Spots5 clinical fellows per year
SalaryGME stipend scale for 2026-27: $73,169 (PGY-2) to $91,399 (PGY-8)
SUO accredited
What stands out
- Multidisciplinary cadaveric surgical anatomy course and an annual MIS/robotic course for surgical trainees
- Program lead
- Kelly Bree
- Apply through
- AUA / SUO Match
- Timeline
- Two weeks before the interview date (2026 interviews: March 30 and April 17)
- Focus
- Robotic, laparoscopic and open surgery for common and rare urologic cancers; multidisciplinary care; clinical and translational research
- Eligibility
- Not statedUSMLE requiredVisa: not stated
- Contact
- Loading contact…
Training
- Structure
- Two years with a research component and a clinical component; length depends on prior research experience, with optional extra research years
- Research
- Each fellow is assigned a full-time MD or PhD basic science mentor; mentored clinical trial design; access to GME pilot grants and grant workshops
- Case numbers
- Penile cancer: more than 50 new patients per year, with a prospective database of 500+ patients (Curtis Pettaway's group)
- Hospital
- UT MD Anderson Cancer Center, Texas Medical Center, Houston
- Faculty
- Neema Navai, Ashish M. Kamat, Louis L. Pisters, Brian F. Chapin, Curtis A. Pettaway, Surena F. Matin, John F. Ward, Jose A. Karam
Requirements (6)
- Completed urology residency; board certified or eligible
- Eligible for a Texas medical licence
- All three USMLE parts completed
- Valid ECFMG certificate for foreign graduates
- Registered SUO member
- SUO application, CV, three letters (one from program director), personal statement, photo